National Institutes of Health HIV Preclinical/Clinical Conference on NeuroAIDS
Conference
Overview
includes event
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents for neurodegenerative disorders to the CNS: implications for treating neuroAIDS [presentation]
Contact
held in geographic location
Bethesda, MD
